Filing Details
- Accession Number:
- 0001437749-23-025513
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-08 17:47:19
- Reporting Period:
- 2023-08-31
- Accepted Time:
- 2023-09-08 17:47:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1537561 | Arch Therapeutics Inc. | ARTH | Surgical & Medical Instruments & Apparatus (3841) | 460524102 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1886766 | Laurence Hicks | C/O Arch Therapeutics, Inc. 235 Walnut Street Suite 6 Framingham MA 01702 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-31 | 10,292 | $0.28 | 10,292 | No | 4 | P | Indirect | Drake Partners |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Drake Partners |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants (right to buy) | Acquisiton | 2023-08-31 | 20,584 | $0.00 | 20,584 | $1.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,584 | 2028-08-31 | No | 4 | A | Indirect |
Footnotes
- The Reporting Person is an owner of Drake Partners. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- The warrants are exercisable after the earlier of (A) the six-month anniversary after the date of issuance and (B) the date that a registration statement registering the shares underlying the warrants is declared effective.
- The warrants were sold as part of a unit with the shares of common stock reported in Table I, at a price of $0.275 per share of common stock and accompanying warrant to purchase two shares of common stock.